Ketola-Kinnula Tanja, Suuronen Riitta, Kontio Risto, Laine Pekka, Lindqvist Christian
Department of Oral and Maxillofacial Surgery, Institute of Dentistry, University of Helsinki, Helsinki, Finland.
J Oral Maxillofac Surg. 2010 Aug;68(8):1753-62. doi: 10.1016/j.joms.2009.07.059. Epub 2009 Dec 16.
The use of bioabsorbable self-reinforced poly(L/DL)lactide 70/30 (SR-PLDLA) miniplates and screws could offer many benefits compared with conventional metallic devices for fixation of access osteotomies in oral cancer surgery. The material neither interferes with imaging nor with postoperative radiotherapy. The plates and screws do not need to be removed. The number of operations can be diminished and rehabilitation with dental implants shortened. The purpose of the present study was to report our experience with bioabsorbable osteosynthesis in the fixation of access osteotomies of the mandible.
A total of 15 patients (11 men and 4 women, mean age 63.1 years) were enrolled in the present study. All patients had oral squamous cell carcinoma. Three patients developed tumor recurrence, 2 of whom had previously undergone radiotherapy. Nine patients had radiotherapy scheduled postoperatively. The osteotomies were a straight-line cut and were situated medially or paramedially. For fixation, SR-PLDLA miniplates and screws (Biosorb 2.0 and 2.4 systems) were used without any maxillomandibular fixation.
The follow-up ranged from 0.3 to 7.1 years (median 3.5). No problems were encountered during the operation. One patient required reoperation owing to failure in fixation. Twelve osteotomy lines (80%) were clinically stable; radiologically, 6 were totally and 3 partly consolidated. During follow-up, 6 nonunions were radiographically noted, 3 of which were clinically stable.
Because of the high incidence of radiologic nonunion, bioabsorbable devices should not yet be used for fixation of access osteotomies in cancer surgery.
与传统金属器械相比,使用生物可吸收自增强聚(L/DL)丙交酯70/30(SR-PLDLA)微型钢板和螺钉固定口腔癌手术中的入路截骨术有诸多益处。该材料既不干扰成像,也不影响术后放疗。钢板和螺钉无需取出。可减少手术次数并缩短牙种植体修复时间。本研究的目的是报告我们使用生物可吸收接骨术固定下颌骨入路截骨术的经验。
本研究共纳入15例患者(11例男性和4例女性,平均年龄63.1岁)。所有患者均患有口腔鳞状细胞癌。3例患者出现肿瘤复发,其中2例曾接受过放疗。9例患者计划术后进行放疗。截骨术为直线切口,位于内侧或近内侧。固定时,使用SR-PLDLA微型钢板和螺钉(Biosorb 2.0和2.4系统),无需任何颌间固定。
随访时间为0.3至7.1年(中位数3.5年)。手术过程中未遇到问题。1例患者因固定失败需要再次手术。12条截骨线(80%)临床稳定;影像学上,6条完全愈合,3条部分愈合。随访期间,影像学检查发现6例骨不连,其中3例临床稳定。
由于放射学骨不连发生率较高,生物可吸收器械目前不应应用于癌症手术中的入路截骨术固定。